# Efficacy of Sodium Glucose Cotransporter 2 Inhibitors on Non-Alcoholic Fatty Liver Disease

> **NCT06739486** · — · NOT_YET_RECRUITING · sponsor: **Assiut University** · enrollment: 100 (estimated)

## Conditions studied

- Non Alcholic Fatty Liver Disease
- Hepatic Steatosis
- Hepatic Fibrosis
- NAFLD (Nonalcoholic Fatty Liver Disease)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06739486
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12-20
- **Primary completion:** 2025-11-20
- **Final completion:** 2025-12-20
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06739486

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06739486, "Efficacy of Sodium Glucose Cotransporter 2 Inhibitors on Non-Alcoholic Fatty Liver Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06739486. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*